Skip to main content
Glama

Opencellid

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint=true, openWorldHint=true, idempotentHint=true, and destructiveHint=false. The description enriches this considerably: it discloses the multi-endpoint cascade ('Each call cascades through several lookup endpoints internally'), the graceful degradation when GLEIF/OpenFIGI are unavailable, the explicit `unresolved` field for identifiers that could not be resolved, and the `figi_candidates` behavior on ambiguity. This goes well beyond annotations and prepares the agent for real-world failure modes.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long (over 300 words) but highly information-dense. It is structured into clear segments (supported types, behavior notes) and front-loads the core action and usage rule. Every sentence adds either a capability, a caution, or a fallback behavior. Minor redundancy exists (e.g., repeating 'figi_candidates' twice), but overall the length is justified for a tool that spans multiple identifier systems and edge cases.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a tool with no output schema and two interdependent parameters, the description covers everything an agent needs: both entity types, input formats (ticker, CIK, ISIN, name), the exact rule for bond issuer names, what identifiers are returned and from which source, the ambiguity handling, and the graceful-degradation path. It even explains that it replaces 2-3 manual lookups, framing its role in the workflow. Nothing critical is missing.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% with both parameters described, but the description for `value` is exceptionally detailed: it explains the entity-name-only rule with a concrete bond example ('NEW YORK ST DORM AUTH' vs. 'NEW YORK ST DORM AUTH revenue bonds'), clarifies that a ticker or CIK can also be passed, and even mentions how ISINs resolve to legal entities. This adds meaning beyond the schema's short one-liners and prevents common misuse.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete example queries, then states the core action: 'resolve a user-spoken NAME to the canonical/official identifiers other tools require as input.' It explicitly distinguishes itself from siblings by being the go-to resolution tool, and the supplementary detail about supported types (company/drug) and the specific identifiers returned (CIK, ticker, LEI, FIGI, RxCUI) leaves no ambiguity about what the tool does.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The first line after the examples says 'Use FIRST whenever you have a name but need an ID.' This is explicit guidance on when to invoke it. It also provides a decision rule for 'company' type with 'IMPLIED vs. name-search', and clarifies that ambiguity is handled by returning candidates. It does not name alternative tools, but given the sibling list, none serve the same resolving purpose, so the guidance is sufficient and clear.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Opencellid toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation2/5

Several tools are near-indistinguishable by role: ask_pipeworx and ask_pipeworx_beta are documented as currently identical, and ask_pipeworx, ask_pipeworx_grounded, and deep_research overlap as lookup/research entry points. The six-tool Polymarket cluster and the suggest_questions/discover_tools pair add further boundary confusion despite very long descriptions.

Naming Consistency3/5

Snake_case is used consistently, and clusters like ask_pipeworx_* and polymarket_* have internal consistency. However, the global convention is mixed: verb_object names (get_cell, resolve_entity, unsubscribe) sit beside noun phrases (entity_profile, recent_changes, cells_in_area) and product-prefixed nouns (pipeworx_feedback, polymarket_edges), so tool names are not predictable from function.

Tool Count2/5

33 tools is too many for a server named Opencellid, especially since only get_cell and cells_in_area actually belong to the cell-tower domain. Even as a broader Pipeworx/data bundle, the set is heavy and includes unrelated one-offs like generate_llms_txt and scan_dependency.

Completeness2/5

For an OpenCellID server, the surface is just two lookups, missing coverage stats, operator-based search, and other natural cell-tower operations. If judged instead as a Pipeworx data-research suite, coverage is broad, but the lack of a coherent stated domain makes obvious gaps and dead ends harder to identify.

Resources